Pages that link to "Q39851951"

The following pages link to Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations. (Q39851951):

Displaying 22 items.

• Gene therapy for metachromatic leukodystrophy. (Q30357745) (← links)
• Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy (Q30541880) (← links)
• Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma (Q34943946) (← links)
• Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts? (Q34982831) (← links)
• When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials (Q35226105) (← links)
• Clinical applications involving CNS gene transfer (Q35899850) (← links)
• Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A (Q36299764) (← links)
• Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis (Q37353812) (← links)
• Reverse pharmacogenetic modulation of the nucleus accumbens reduces ethanol consumption in a limited access paradigm (Q37409569) (← links)
• Emerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality. (Q37876354) (← links)
• Novel siRNA delivery strategy: a new "strand" in CNS translational medicine? (Q38091009) (← links)
• Fetal neurosurgery: current state of the art. (Q39734933) (← links)
• Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. (Q40120885) (← links)
• Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. (Q40277701) (← links)
• Toward a gene therapy for neurological and somatic MPSIIIA (Q41927384) (← links)
• Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy (Q42176546) (← links)
• Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates (Q42198683) (← links)
• AAVrh.10-mediated APOE2 CNS Gene Therapy for APOE4-associated Alzheimer's Disease (Q48510056) (← links)
• Gene therapy for psychiatric disorders (Q85789509) (← links)
• Emerging treatments for progressive myoclonus epilepsies (Q90175159) (← links)
• Gene Therapy Tools for Brain Diseases (Q91938470) (← links)
• Bringing balance to the force-regulatable gene therapy for epilepsy (Q92357068) (← links)